{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:40:09Z","timestamp":1745383209156,"version":"3.40.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,22]]},"DOI":"10.7759\/cureus.82813","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:01:25Z","timestamp":1745380885000},"source":"Crossref","is-referenced-by-count":0,"title":["Management and Outcomes of Intracranial Hemorrhage in Atrial Fibrillation Patients: Highlighting Practices in Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Abdulaziz M","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama A","family":"Alkulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feras","family":"Fatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad S","family":"Subahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah F","family":"Tayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arwa","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moajeb","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Almehmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel S","year":"2002","unstructured":"Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002, 415:219-26. 10.1038\/415219a","journal-title":"Nature"},{"key":"ref2","article-title":"Epidemiology of and risk factors for atrial fibrillation","author":"Ganz LI","year":"2025","unstructured":"Ganz LI, Spragg D. Epidemiology of and risk factors for atrial fibrillation. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin EJ","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998, 98:946-52. 10.1161\/01.cir.98.10.946","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh SS","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, et al.. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014, 129:837-47. 10.1161\/CIRCULATIONAHA.113.005119","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61300-2","article-title":"Management of atrial fibrillation","volume":"18","author":"Lip GY","year":"2007","unstructured":"Lip GY, Tse HF. Management of atrial fibrillation. Lancet. 2007, 18:604-18. 10.1016\/S0140-6736(07)61300-2","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al.. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014, 130:2071-104. 10.1161\/CIR.0000000000000040","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.059","article-title":"Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis","volume":"75","author":"Kuno T","year":"2020","unstructured":"Kuno T, Takagi H, Ando T, et al.. Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis. J Am Coll Cardiol. 2020, 75:273-85. 10.1016\/j.jacc.2019.10.059","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-731638","article-title":"Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy","volume":"129","author":"Lopes RD","year":"2017","unstructured":"Lopes RD, Guimar\u00e3es PO, Kolls BJ, et al.. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood. 2017, 129:2980-7. 10.1182\/blood-2016-08-731638","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.031","article-title":"Incidence, mortality, and risk factors for oral anticoagulant-associated intracranial hemorrhage in patients with atrial fibrillation","volume":"23","author":"Grysiewicz R","year":"2014","unstructured":"Grysiewicz R, Gorelick PB. Incidence, mortality, and risk factors for oral anticoagulant-associated intracranial hemorrhage in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2014, 23:2479-88. 10.1016\/j.jstrokecerebrovasdis.2014.06.031","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu463","article-title":"Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial","volume":"36","author":"Held C","year":"2015","unstructured":"Held C, Hylek EM, Alexander JH, et al.. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. Eur Heart J. 2015, 36:1264-72. 10.1093\/eurheartj\/ehu463","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg SM","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, et al.. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2022, 53:e282-361. 10.1161\/STR.0000000000000407","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.08.017","article-title":"Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation","volume":"312","author":"Maeda K","year":"2012","unstructured":"Maeda K, Koga M, Okada Y, et al.. Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation. J Neurol Sci. 2012, 312:82-5. 10.1016\/j.jns.2011.08.017","journal-title":"J Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004235","article-title":"Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation","volume":"89","author":"Korompoki E","year":"2017","unstructured":"Korompoki E, Filippidis FT, Nielsen PB, et al.. Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. Neurology. 2017, 89:687-96. 10.1212\/WNL.0000000000004235","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.wnsx.2022.100148","article-title":"Anticoagulation holiday: resumption of direct oral anticoagulants for atrial fibrillation in patients with index traumatic intracranial hemorrhage","volume":"17","author":"Ghenbot Y","year":"2023","unstructured":"Ghenbot Y, Arena JD, Howard S, Wathen C, Kumar MA, Schuster JM. Anticoagulation holiday: resumption of direct oral anticoagulants for atrial fibrillation in patients with index traumatic intracranial hemorrhage. World Neurosurg X. 2023, 17:100148. 10.1016\/j.wnsx.2022.100148","journal-title":"World Neurosurg X"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000078311.18928.16","article-title":"Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis","volume":"34","author":"Eckman MH","year":"2003","unstructured":"Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003, 34:1710-6. 10.1161\/01.STR.0000078311.18928.16","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.9369","article-title":"Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation","volume":"177","author":"Nielsen PB","year":"2017","unstructured":"Nielsen PB, Larsen TB, Skj\u00f8th F, Lip GY. Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation. JAMA Intern Med. 2017, 177:563-70. 10.1001\/jamainternmed.2016.9369","journal-title":"JAMA Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022849","article-title":"Post-intracranial hemorrhage antithrombotic therapy in patients with atrial fibrillation","volume":"11","author":"Lin SY","year":"2022","unstructured":"Lin SY, Chang YC, Lin FJ, Tang SC, Dong YH, Wang CC. Post-intracranial hemorrhage antithrombotic therapy in patients with atrial fibrillation. J Am Heart Assoc. 2022, 11:e022849. 10.1161\/JAHA.121.022849","journal-title":"J Am Heart Assoc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.05.016","article-title":"Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage","volume":"13","author":"Park YA","year":"2016","unstructured":"Park YA, Uhm JS, Pak HN, Lee MH, Joung B. Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage. Heart Rhythm. 2016, 13:1794-802. 10.1016\/j.hrthm.2016.05.016","journal-title":"Heart Rhythm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31878-6","article-title":"Intracerebral haemorrhage: current approaches to acute management","volume":"6","author":"Cordonnier C","year":"2018","unstructured":"Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018, 6:1257-68. 10.1016\/S0140-6736(18)31878-6","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials","volume":"15","author":"Ruff CT","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al.. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet. 2014, 15:955-62. 10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013343","article-title":"Anticoagulant-associated intracranial hemorrhage in the era of reversal agents","volume":"48","author":"Steiner T","year":"2017","unstructured":"Steiner T, Weitz JI, Veltkamp R. Anticoagulant-associated intracranial hemorrhage in the era of reversal agents. Stroke. 2017, 48:1432-7. 10.1161\/STROKEAHA.116.013343","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel J","year":"2021","unstructured":"Steffel J, Collins R, Antz M, et al.. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021, 23:1612-76. 10.1093\/europace\/euab065","journal-title":"Europace"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/2396987319863606","article-title":"Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018","volume":"4","author":"Ahmed N","year":"2019","unstructured":"Ahmed N, Audebert H, Turc G, et al.. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018. Eur Stroke J. 2019, 4:307-17. 10.1177\/2396987319863606","journal-title":"Eur Stroke J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip GY","year":"2018","unstructured":"Lip GY, Banerjee A, Boriani G, et al.. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018, 154:1121-201. 10.1016\/j.chest.2018.07.040","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.1085","article-title":"2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on expert consensus decision pathways","volume":"70","author":"Tomaselli GF","year":"2017","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A, et al.. 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on expert consensus decision pathways. J Am Coll Cardiol. 2017, 70:3042-67. 10.1016\/j.jacc.2017.09.1085","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342733-management-and-outcomes-of-intracranial-hemorrhage-in-atrial-fibrillation-patients-highlighting-practices-in-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:01:25Z","timestamp":1745380885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342733-management-and-outcomes-of-intracranial-hemorrhage-in-atrial-fibrillation-patients-highlighting-practices-in-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.82813","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}